Join to View Full Profile
919 Westfall RdBldg C, Suite 215Rochester, NY 14618
Phone+1 585-341-7500
Fax+1 585-341-7510
Dr. Biglan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Rochester Medical CenterFellowship, Neuromuscular Medicine (Neurology), 2000 - 2003
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Neurology, 1997 - 2000
Main Line Health System/Lankenau Medical CenterInternship, Internal Medicine, 1996 - 1997- Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1996
Certifications & Licensure
NY State Medical License 2000 - 2027
MD State Medical License 2003 - 2006
PA State Medical License 1997 - 2002
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- A Pilot, Randomized Controlled Trial of Group Visits for Persons With Parkinson's Disease Start of enrollment: 2007 Sep 01
- Pilot Randomized Controlled Trial of Telemedicine for Individuals With Parkinson Disease in a Rural Population Start of enrollment: 2008 Apr 01
- Creatine Safety, Tolerability, & Efficacy in Huntington's Disease (CREST-E) Start of enrollment: 2009 Sep 01
- Join now to see all
Publications & Presentations
PubMed
- Using Clinical Scales and Digital Measures to Explore Falls in Patients with Lewy Body Dementia.Chakib Battioui, Albert Man, Melissa Pugh, Jian Wang, Xiangnan Dang
Digital Biomarkers. 2023-06-21 - 25 citationsSafety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial.Kevin Biglan, Leanne Munsie, Kjell A. Svensson, Paul A. Ardayfio, Melissa Pugh
Movement Disorders. 2021-12-02 - 4 citationsSafety, Tolerability, and Pharmacokinetics of Mevidalen (LY3154207), a Centrally Acting Dopamine D1 Receptor-Positive Allosteric Modulator, in Patients With Parkinson ...Darren Wilbraham, Kevin Biglan, Kjell A. Svensson, Max Tsai, Melissa Pugh
Clinical Pharmacology in Drug Development. 2021-10-19
Press Mentions
Where Teleneurology Is Expanding, and Who Is Paying for ItDecember 8th, 2016
AMC Health and University of Rochester Medical Center Deploy Virtual Video Visits for Phase III Clinical Trial in Parkinson’s Disease: REACT-PD StudyJune 22nd, 2016- Medical School Launches Parkinson’s Telemedicine SolutionMay 10th, 2016
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
